Acidex Advance oral suspension aniseed
BNF presentation 0101021B0BQACAL within chapter Gastro-Intestinal System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0101021B0BQACAL
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
23,171
NHS spend (£)
£93,961.26
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 3,330 |
| February 2025 | 39 |
| December 2024 | 1,051 |
| November 2024 | 3,546 |
| October 2024 | 3,428 |
| September 2024 | 12 |
| August 2024 | 375 |
| July 2024 | 3,445 |
| May 2024 | 976 |
| July 2021 | 1,353 |
| June 2021 | 836 |
| December 2020 | 2,282 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 206 | No data available |
| Unknown pharmacy | 166 | No data available |
| Unknown pharmacy | 164 | No data available |
| Unknown pharmacy | 163 | No data available |
| Unknown pharmacy | 161 | No data available |
| Unknown pharmacy | 138 | No data available |
|
Asa Medical Group
ODS C86609
|
127 | 02X - SOUTH YORKSHIRE ICB |
| Unknown pharmacy | 123 | No data available |
| Unknown pharmacy | 116 | No data available |
|
Dinnington Group Practice
ODS C87002
|
111 | 03L - SOUTH YORKSHIRE ICB |